We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$335M
AUM Growth
+$11.6M
Cap. Flow
+$500K
Cap. Flow %
0.15%
Top 10 Hldgs %
27.98%
Holding
112
New
6
Increased
46
Reduced
32
Closed
2

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$751K
2
AMZN icon
Amazon
AMZN
+$647K
3
DIS icon
Walt Disney
DIS
+$567K
4
INTC icon
Intel
INTC
+$537K
5
VZ icon
Verizon
VZ
+$519K

Sector Composition

Rank Sector Weight
1 Healthcare 13.97%
2 Technology 13.86%
3 Consumer Staples 11.23%
4 Industrials 11.01%
5 Consumer Discretionary 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGA icon
51
Magna International
MGA
$19.1B
$2.66M 0.8%
49,705
+7,095
+17% +$411K
CTAS icon
52
Cintas
CTAS
$80.7B
$2.56M 0.76%
22,120
VTI icon
53
Vanguard Morningstar Total Stock Market ETF
VTI
$686B
$2.54M 0.76%
12,459
+79
+0.6% +$15.8K
IJH icon
54
iShares Core S&P Mid-Cap ETF
IJH
$126B
$2.48M 0.74%
49,520
-2,285
-4% -$116K
USB icon
55
US Bancorp
USB
$101B
$2.25M 0.67%
62,488
+16,862
+37% +$751K
VB icon
56
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$2.17M 0.65%
11,425
-125
-1% -$24.2K
IBB icon
57
iShares Biotechnology ETF
IBB
$9.55B
$2.11M 0.63%
16,339
-57
-0.3% -$7.46K
BBH icon
58
VanEck Biotech ETF
BBH
$412M
$2.06M 0.62%
12,721
-40
-0.3% -$6.47K
HYG icon
59
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.03M 0.61%
26,885
-1,564
-5% -$117K
IAU icon
60
iShares Gold Trust
IAU
$65.4B
$2.01M 0.6%
53,823
-15
-0% -$538
HYD icon
61
VanEck High Yield Muni ETF
HYD
$4.44B
$1.77M 0.53%
34,158
+1,795
+6% +$92.7K
LLY icon
62
Eli Lilly
LLY
$1.06T
$1.52M 0.45%
4,433
JNJ icon
63
Johnson & Johnson
JNJ
$620B
$1.51M 0.45%
9,773
-22
-0.2% -$3.55K
CVX icon
64
Chevron
CVX
$377B
$1.45M 0.43%
8,873
-110
-1% -$18.4K
SYK icon
65
Stryker
SYK
$130B
$1.24M 0.37%
4,354
GOOG icon
66
Alphabet (Google) Class C
GOOG
$4.61T
$1.23M 0.37%
11,820
VEU icon
67
Vanguard FTSE All-World ex-US ETF
VEU
$68.3B
$1.18M 0.35%
22,134
VEA icon
68
Vanguard FTSE Developed Markets ETF
VEA
$235B
$1.04M 0.31%
23,116
+1,951
+9% +$86.9K
PFE icon
69
Pfizer
PFE
$146B
$972K 0.29%
23,832
-73
-0.3% -$3.15K
ORCL icon
70
Oracle
ORCL
$415B
$948K 0.28%
10,207
-71
-0.7% -$6.23K
PAYX icon
71
Paychex
PAYX
$42B
$879K 0.26%
7,675
CAT icon
72
Caterpillar
CAT
$414B
$810K 0.24%
3,542
PFF icon
73
iShares Preferred and Income Securities ETF
PFF
$13.3B
$754K 0.23%
24,153
+707
+3% +$22.7K
SYY icon
74
Sysco
SYY
$40.3B
$632K 0.19%
8,190
ITW icon
75
Illinois Tool Works
ITW
$85.3B
$628K 0.19%
2,580
-14
-0.5% -$3.27K

Similar funds

Boston Research & Management's Q1 2023 Portfolio in Review

As of Q1 2023, Boston Research & Management held 112 positions worth $335M, up 3.6% from $323M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Boston Research & Management's Q1 2023 filing shows 6 new, 46 increased, 32 reduced and 2 closed positions. Its largest new stake was Group 1 Automotive: 1,046 shares worth $236K. The largest sale was C.H. Robinson, an estimated $4.28M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q1 2023 buy was Group 1 Automotive: 1,046 shares worth $236K.
  • Boston Research & Management added most to US Bancorp in Q1 2023, an estimated $751K increase.
  • Boston Research & Management's biggest Q1 2023 reduction was C.H. Robinson, cutting an estimated $4.28M.
  • Boston Research & Management fully exited Shell in Q1 2023, selling an estimated $378K.
  • Boston Research & Management's ten largest holdings make up 28% of its $335M portfolio in Q1 2023.
  • Boston Research & Management opened 6 new positions and closed 2 in Q1 2023.
  • Boston Research & Management's portfolio value rose 3.6% quarter-over-quarter to $335M.

Based on Boston Research & Management's 13F filing for Q1 2023, filed 10 May 2023.